BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8134127)

  • 61. Multiple tumors in a child with germ-line mutations in TP53 and PTEN.
    Plon SE; Pirics ML; Nuchtern J; Hicks J; Russell H; Agrawal S; Zbuk K; Eng C; Hegde M; Chin EL
    N Engl J Med; 2008 Jul; 359(5):537-9. PubMed ID: 18669439
    [No Abstract]   [Full Text] [Related]  

  • 62. Absence of p53 germ-line mutations in bilateral breast cancer patients.
    Lidereau R; Soussi T
    Hum Genet; 1992 May; 89(2):250-2. PubMed ID: 1587536
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Li-Fraumeni syndrome.
    Birch JM
    Eur J Cancer; 1994; 30A(13):1935-41. PubMed ID: 7734204
    [No Abstract]   [Full Text] [Related]  

  • 64. Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma.
    Metzger AK; Sheffield VC; Duyk G; Daneshvar L; Edwards MS; Cogen PH
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7825-9. PubMed ID: 1679237
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic transmission of susceptibility to cancer in families of children with soft tissue sarcomas.
    Moutou C; Le Bihan C; Chompret A; Poisson N; Brugières L; Bressac B; Feunteun J; Lemerle J; Bonaïti-Pellié C
    Cancer; 1996 Oct; 78(7):1483-91. PubMed ID: 8839555
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Germline p53 mutation in a Micronesian child with adrenocortical carcinoma and subsequent osteosarcoma.
    Delaney HM; Prauner RD; Person DA
    J Pediatr Hematol Oncol; 2008 Nov; 30(11):803-6. PubMed ID: 18989156
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.
    Iavarone A; Matthay KK; Steinkirchner TM; Israel MA
    Proc Natl Acad Sci U S A; 1992 May; 89(9):4207-9. PubMed ID: 1349175
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incidence of germ-line p53 mutations in patients with gliomas.
    Li YJ; Sanson M; Hoang-Xuan K; Delattre JY; Poisson M; Thomas G; Hamelin R
    Int J Cancer; 1995 Dec; 64(6):383-7. PubMed ID: 8550239
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A database of germline p53 mutations in cancer-prone families.
    Sedlacek Z; Kodet R; Poustka A; Goetz P
    Nucleic Acids Res; 1998 Jan; 26(1):214-5. PubMed ID: 9399838
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.
    Hwang SJ; Lozano G; Amos CI; Strong LC
    Am J Hum Genet; 2003 Apr; 72(4):975-83. PubMed ID: 12610779
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations.
    Russo CL; McIntyre J; Goorin AM; Link MP; Gebhardt MC; Friend SH
    Med Pediatr Oncol; 1994; 23(4):354-8. PubMed ID: 8058007
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Familial brain tumour syndrome associated with a p53 germline deletion of codon 236.
    Lübbe J; von Ammon K; Watanabe K; Hegi ME; Kleihues P
    Brain Pathol; 1995 Jan; 5(1):15-23. PubMed ID: 7767487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Choroid plexus tumors in the breast cancer-sarcoma syndrome.
    Garber JE; Burke EM; Lavally BL; Billett AL; Sallan SE; Scott RM; Kupsky W; Li FP
    Cancer; 1990 Dec; 66(12):2658-60. PubMed ID: 2249207
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prospective study of a family cancer syndrome.
    Li FP; Fraumeni JF
    JAMA; 1982 May; 247(19):2692-4. PubMed ID: 7077763
    [No Abstract]   [Full Text] [Related]  

  • 75. A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families.
    Porter DE; Holden ST; Steel CM; Cohen BB; Wallace MR; Reid R
    J Bone Joint Surg Br; 1992 Nov; 74(6):883-6. PubMed ID: 1447251
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Codon-level co-occurrences of germline variants and somatic mutations in cancer are rare but often lead to incorrect variant annotation and underestimated impact prediction.
    Koire A; Kim YW; Wang J; Katsonis P; Jin H; Lichtarge O
    PLoS One; 2017; 12(3):e0174766. PubMed ID: 28350864
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
    Lustbader ED; Williams WR; Bondy ML; Strom S; Strong LC
    Am J Hum Genet; 1992 Aug; 51(2):344-56. PubMed ID: 1642235
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cancer in relatives of survivors of childhood sarcoma.
    Burke E; Li FP; Janov AJ; Batter S; Grier H; Goorin A
    Cancer; 1991 Mar; 67(5):1467-9. PubMed ID: 1991315
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Familial aggregation of cancer from proband cases with childhood adrenal cortical carcinoma.
    Tsunematsu Y; Watanabe S; Oka T; Tsukamoto T; Kawa-Ha K; Hirata Y; Yamanaka H; Ohira M; Ono M
    Jpn J Cancer Res; 1991 Aug; 82(8):893-900. PubMed ID: 1910026
    [TBL] [Abstract][Full Text] [Related]  

  • 80. p53 codon 213 (A-G) polymorphism in a Turkish population.
    Ilhan I; Erekul S; Ateşalp S; Ilhan O; Akar N
    Pediatr Hematol Oncol; 1995; 12(5):499-501. PubMed ID: 8519637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.